Loading...
BUY now. REZI is trading near key support (S1 ~33.68) with improving downside momentum (MACD bearish but contracting), strong insider buying (+287.76% last month), and distinctly bullish options positioning (low put/call ratios). With earnings on 2026-02-19 (after hours) as a clear upcoming catalyst and Q3’25 profitability inflecting sharply higher, the risk/reward favors initiating immediately rather than waiting for a “perfect” entry.
Price/levels: REZI 34.15 is below the pivot (35.666) and close to S1 (33.68); upside levels are R1 37.652 and R2 38.88. Momentum: MACD histogram -0.44 (bearish) but “negatively contracting,” suggesting selling pressure is easing. RSI(6) ~36.3 is weak/near-oversold territory and consistent with a bounce setup rather than an extended uptrend. MAs: converging moving averages imply consolidation after a prior move; the next directional break likely comes from reclaiming the pivot (35.67) or losing S1 (~33.68). Pattern-based outlook provided: +1.63% next day (60% odds), +5.17% next week, +3.55% next month—supports a near-term rebound bias.
Intellectia Proprietary Trading Signals

Insider activity: insiders are buying, with buying amount up ~287.76% over the last month (a meaningful positive signal).
Earnings catalyst: QDEC 2025 earnings on 2026-02-19 after hours (Street EPS est. ~0.38).
Profitability inflection: latest quarter shows a major YoY jump in net income and EPS, plus gross margin improvement.
Trend not fully repaired: price remains below pivot resistance (~35.
and MACD is still negative (even though improving).
Growth quality: revenue growth is modest (~+1.97% YoY), so the big EPS/net income jump may be partly mix/one-time/operational leverage effects rather than strong top-line acceleration.
No supportive near-term news flow: no recent news items to drive immediate momentum.
Latest reported quarter: 2025/Q3. Revenue: $1.864B (+1.97% YoY) shows steady but slow top-line growth. Profitability: Net income $131M (+1090.91% YoY) and EPS $0.85 (+1114.29% YoY) indicate a sharp earnings inflection (likely margin/operating leverage driven). Gross margin: 28.17% (+4.03% YoY) confirms underlying margin improvement, supporting the durability of the earnings rebound if it persists.
No analyst rating/price target change data was provided, so there’s no confirmed recent trend in upgrades/downgrades or target revisions. Wall Street-style pros (based on provided fundamentals): strong margin improvement and outsized EPS/net income growth; insider buying aligns with management confidence. Cons: modest revenue growth and a chart that’s still technically below key resistance (pivot ~35.67). Net view from the available data skews positive, but confirmation would come from reclaiming the pivot and/or strong earnings guidance.